|
GNA13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89919999621569E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.17200002217544E-09 |
| Normal-vs-Stage2 |
1.023570E-03 |
| Normal-vs-Stage3 |
1.822560E-03 |
| Normal-vs-Stage4 |
3.583500E-03 |
| Stage1-vs-Stage2 |
7.065200E-01 |
| Stage1-vs-Stage3 |
3.908400E-02 |
| Stage1-vs-Stage4 |
6.675700E-02 |
| Stage2-vs-Stage3 |
1.430380E-01 |
| Stage2-vs-Stage4 |
1.508780E-01 |
| Stage3-vs-Stage4 |
9.947400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.36340000400637E-08 |
| Normal-vs-AfricanAmerican |
1.094380E-01 |
| Normal-vs-Asian |
1.173790E-01 |
| Caucasian-vs-AfricanAmerican |
4.796000E-03 |
| Caucasian-vs-Asian |
5.752800E-01 |
| AfricanAmerican-vs-Asian |
9.106000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80320000042755E-07 |
| Normal-vs-Female |
1.48290000001605E-06 |
| Male-vs-Female |
8.177800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.298400E-03 |
| Normal-vs-Age(41-60Yrs) |
8.23079999712206E-08 |
| Normal-vs-Age(61-80Yrs) |
1.74060000002196E-06 |
| Normal-vs-Age(81-100Yrs) |
1.167350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.765200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.165800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.682200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.551000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.253400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.193400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.54430000000239E-05 |
| Normal-vs-Grade 2 |
3.32109995060392E-09 |
| Normal-vs-Grade 3 |
4.13169999999852E-05 |
| Normal-vs-Grade 4 |
1.548360E-02 |
| Grade 1-vs-Grade 2 |
4.720400E-01 |
| Grade 1-vs-Grade 3 |
3.929800E-02 |
| Grade 1-vs-Grade 4 |
5.954500E-02 |
| Grade 2-vs-Grade 3 |
9.263300E-03 |
| Grade 2-vs-Grade 4 |
3.223700E-02 |
| Grade 3-vs-Grade 4 |
5.976600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.42219569454483E-11 |
| Normal-vs-ccB subtype |
1.555490E-04 |
| ccA subtype-vs-ccB subtype |
1.523800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.35640000015403E-07 |
| Normal-vs-N1 |
5.408200E-02 |
| N0-vs-N1 |
8.332800E-01 |
|
|
